Susquehanna International Group, LLP Athira Pharma, Inc. Transaction History

Susquehanna International Group, LLP

$641 Billion
Q4 2024

A detailed history of Susquehanna International Group, LLP transactions in Athira Pharma, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 49,283 shares of ATHA stock, worth $22,177. This represents 0.0% of its overall portfolio holdings.

Number of Shares

49,283

Previous 18,351 168.56%

Holding current value

$22,177

Previous $8,000 262.5%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$0.42 - $0.8 $12,991 - $24,745	30,932 Added 168.56%	49,283 $29,000
Q3 2024 Nov 14, 2024	SELL	$0.42 - $3.43 $18,257 - $149,102	-43,470 Reduced 70.32%	18,351 $8,000
Q2 2024 Aug 15, 2024	SELL	$1.92 - $2.71 $60,672 - $85,636	-31,600 Reduced 33.83%	61,821 $163,000
Q1 2024 May 07, 2024	BUY	$2.24 - $4.15 $99,104 - $183,608	44,243 Added 89.97%	93,421 $255,000
Q4 2023 Feb 14, 2024	BUY	$1.39 - $2.46 $28,771 - $50,919	20,699 Added 72.68%	49,178 $119,000
Q3 2023 Nov 14, 2023	SELL	$1.9 - $3.16 $36,214 - $60,229	-19,060 Reduced 40.09%	28,479 $57,000
Q2 2023 Aug 11, 2023	SELL	$2.36 - $3.59 $7,500 - $11,409	-3,178 Reduced 6.27%	47,539 $140,000
Q1 2023 May 16, 2023	SELL	$2.26 - $4.22 $58,007 - $108,314	-25,667 Reduced 33.6%	50,717 $126,000
Q4 2022 Feb 14, 2023	BUY	$2.76 - $3.71 $37,483 - $50,385	13,581 Added 21.62%	76,384 $242,000
Q3 2022 Nov 14, 2022	SELL	$2.93 - $3.96 $513,505 - $694,021	-175,258 Reduced 73.62%	62,803 $187,000
Q2 2022 Aug 15, 2022	SELL	$2.74 - $13.43 $18,574 - $91,041	-6,779 Reduced 2.77%	238,061 $726,000
Q1 2022 May 16, 2022	SELL	$8.96 - $13.51 $2.25 Million - $3.39 Million	-251,035 Reduced 50.62%	244,840 $3.31 Million
Q4 2021 Feb 14, 2022	BUY	$9.17 - $16.39 $2.42 Million - $4.32 Million	263,666 Added 113.55%	495,875 $6.46 Million
Q3 2021 Nov 15, 2021	BUY	$9.15 - $11.09 $624,432 - $756,825	68,244 Added 41.62%	232,209 $2.18 Million
Q2 2021 Aug 11, 2021	BUY	$10.24 - $20.87 $1.68 Million - $3.42 Million	163,965 New	163,965 $1.68 Million

Others Institutions Holding ATHA

# of Institutions

Shares Held

18.8M

Call Options Held

17.2K

Put Options Held

800

View Full List

About Athira Pharma, Inc.

Ticker ATHA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,817,700
Market Cap $17M
Description
Athira Pharma, Inc., a late clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation. The company's lead product candidate is ATH-1017, a blood brain barrier-penetrating, small molecule HGF/MET positive modulator that is in LIFT-AD Phase 3 and ACT-AD Phase 2 clinical tri...

More about ATHA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account

Susquehanna International Group, LLP Athira Pharma, Inc. Transaction History